Aşırı Terlemenin Ruh Sağlığı Üzerindeki Etkileri

Öz

Aksiller ve palmar hiperhidroz, yalnızca fiziksel aşırı terleme ile sınırlı olmayan; sosyal, duygusal ve psikiyatrik açıdan geniş bir yelpazede olumsuz sonuçlara yol açan kronik bir otonomik disfonksiyondur. Bu derlemede hiperhidrozun ruh sağlığı üzerindeki etkileri güncel literatür ışığında incelendi. PubMed’de ve webde yayımlanan sistematik derlemeler, meta-analizler, kohortlar ve nitel araştırmalar dâhil edilerek analiz edildi. Anksiyete, depresyon, sosyal kaygı, stigma, yaşam kalitesi ve cerrahi tedavi sonrası psikososyal sonuçlar değerlendirildi. Meta-analizler hiperhidrozun anksiyete ve depresyon için OR risk oluşturduğunu göstermektedir. Aksiller hiperhidroz stigma ve özgüven kaybıyla ilişkilidir, palmar hiperhidroz ise performans kaygısı ve sosyal fobiyi tetiklemektedir. Oksibutinin, botulinum toksin A, mikrodalga tedavi ve sempatektomi gibi tedavi yöntemleri yalnızca fiziksel terlemeyi değil, ruhsal iyilik hâlini de anlamlı biçimde iyileştirmektedir. Hiperhidroz biyopsikososyal bir hastalık olarak ele alınmalı, semptom kontrolü ile birlikte psikiyatrik değerlendirme ve yaşam kalitesi odağı mutlaka bütüncül yaklaşıma dâhil edilmelidir. Özellikle ETS öncesi psikososyal değerlendirme hasta memnuniyeti için kritiktir.

Anahtar Kelimeler

• Aşırı terleme
• ruh sağlığı
• anksiyete
• depresyon
• sempatektomi

Effects of hyperhidrosis on mental health

Öz

Axillary and palmar hyperhidrosis is a chronic autonomic disorder with significant psychological and social consequences. This review examines the mental health impact of hyperhidrosis by integrating recent literature. PubMed-indexed articles from the web, including systematic reviews, meta-analyses, cohort studies, and qualitative reports, were evaluated. Key outcomes included anxiety, depression, social anxiety, stigma, quality of life, and the psychosocial effects of medical and surgical treatments. Meta-analytic findings show markedly increased risks of anxiety and depression among individuals with primary hyperhidrosis. Axillary hyperhidrosis is strongly associated with stigma and lowered self-esteem, while palmar hyperhidrosis triggers performance anxiety and social phobia. Medical therapies, such as oxybutynin, botulinum toxin A, and microwave therapy, as well as endoscopic thoracic sympathectomy, significantly improve both physical symptoms and psychological well-being. Hyperhidrosis should be regarded as a biopsychosocial condition. Comprehensive management must include psychiatric screening and quality-of-life assessment alongside somatic treatment. Preoperative psychosocial evaluation is essential in ETS candidates.

Anahtar Kelimeler

• hyperhidrosis
• mental health
• anxiety
• depression
• sympathectomy

Kaynakça

1. Hashimoto EN, Cataneo DC, Reis TAD, et al. Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol. 2018;44:292-8.
2. Liu Y, Bahar R, Kalia S, et al. Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver. PLoS One. 2016;11:e0153719.
3. Maazi M, Leung AKC, Lam JM. Primary hyperhidrosis: an updated review. Drugs Context. 2025;14:2025-3-2.
4. Monga P, Manjhi M, Sagar V, et al. Effect of hyperhidrosis on quality of life and its correlation with anxiety. IP Indian J Clin Exp Dermatol. 2024;10:409-14.
5. Karaca Ş, Emül HM, Kulaç M, et al. Hiperhidrozlu Hastaların Anksiyete Düzeylerinin Sağlıklılarla Karşılaştırılması. Turkderm-Turk Arch Dermatol Venereol. 2007;41:51-3.
6. Zimmer D, Flores J, Felipes RS, et al. Sweat Smarter, Not Harder: Fresh Approaches to Occlusive Hyperhidrosis. ARC J Dermatol. 2025;8:17-30.
7. Kristensen JK, Möller S, Vestergaard DG, et al. Anxiety and Depression in Primary Hyperhidrosis: An Observational Study of 95 Consecutive Swedish Outpatients. Acta Derm Venereol. 2020;100:adv00240.
8. Hamm H. Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin. 2014;32:467-76.

9. Sharifi S, Jafferany M. Psychosocial Impact of Pediatric and Adolescent Hyperhidrosis: A Systematic Review and Call for Research. J Cosmet Dermatol. 2025;24:e70213.
10. Zink N. Hyperhidrose und Hochstapler-Syndrom: eine häufige Kombination. MMW Fortschr Med. 2024;166:18-9.
11. Lenefsky M, Rice ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care. 2018;24:-S0.
12. Doolittle J, Walker P, Mills T, et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308:743-9.
13. Vazquez LD, Staples NL, Sears SF, et al. Psychosocial functioning of patients after endoscopic thoracic sympathectomy. Eur J Cardiothorac Surg. 2011;39:1018-21.
14. Wu JY, Xiong JK, Huang CB, et al. Compensatory hyperhidrosis following endoscopic thoracic sympathectomy: a 5-year follow-up study of risk factors and symptom progression. J Cardiothorac Surg. 2025;21:22.
15. Campanati A, Gregoriou S, Milia-Argyti A, et al. The pharmacological treatment and management of hyperhidrosis. Expert Opin Pharmacother. 2022;23:1217-31.
16. Henning MAS, Jemec GBE, Pedersen OB, et al. Cluster Analysis Identifies Clinical Phenotypes of Primary Hyperhidrosis. Skin Pharmacol Physiol. 2024;37:63-9.
17. Kamudoni P, Mueller B, Halford J, et al. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes. 2017;15:121.
18. Saigaal DE, Shahzad A, Tahir R, et al. Prevalence of Primary Palmar Hyperhidrosis and its Impact on Hand Grip Strength and Quality of Life. AKEMU. 2023;29:167-73.
19. Parashar K, Adlam T, Potts G. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature. Am J Clin Dermatol. 2023;24:187-98.
20. Schneier FR, Heimberg RG, Liebowitz MR, et al. Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis. Compr Psychiatry. 2012;53:1181-6.
21. Kristensen JK, Nielsen C. Decreased work productivity due to primary palmar hyperhidrosis. What is the cost? Skin Health Dis. 2021;1:e24.
22. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36:455-70.
23. Ginsburg IH. The psychosocial impact of skin disease. Dermatol Clin. 1996;14:473-84.
24. VIDA Dermatology, 2023. The social and emotional impact of hyperhidrosis. VIDA Dermatology. https://vidadermatology.com/blog/social-and-emotional-impact-of-hyperhidrosis/
25. Global Market Insights, 2024. Hyperhidrosis treatment market – By type (axillary, palmar, plantar), treatment (topical, oral [anticholinergics], botulinum toxin injections), age (below 50, above 50 years), end user (hospitals, ASCs, dermatology clinics), global forecast (2024–2032). Global Market Insights. https://www.marketresearch.com/One-Off-Global-Market-Insights-v4130/Hyperhidrosis-Treatment-Type-Axillary-Palmar-37967097/
26. Kamikava DYF, Wolosker N, Silva MFAD, et al. Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin. Clinics (Sao Paulo). 2021;76:e2892.
27. Kowalski JW, Eadie N, Dagget S, et al. Validity and reliability of the hyperhidrosis disease severity scale (HDSS). JAAD. 2004;50(Suppl):P51.
28. Bahar R, Zhou P, Liu Y, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75:1126-33.
29. Bragança GM, Lima SO, Pinto Neto AF, et al. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras Dermatol. 2014;89:230-5.
30. Weber A, Heger S, Sinkgraven R. Psychosocial aspects of patients with focal hyperhidrosis: Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol. 2005;152:342–5.
31. Lueckel S, Bechara FG, Feise K, et al. Microwave thermolysis for axillary hyperhidrosis: psychological outcomes. Lasers Surg Med. 2023;55:145-52.
32. Vazquez LD, Staples NL, Sears SF, et al. Psychosocial functioning of patients after endoscopic thoracic sympathectomy. Eur J Cardiothorac Surg. 2011;39:1018-21.
33. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).